What Is Fibrin? The Protein Behind Blood Clots

What is fibrin, and why should you care? Fibrin is the protein that gives blood clots their structure — and when fibrin levels fall out of balance, the consequences can range from deep vein thrombosis to heart attack and stroke. This guide answers the question "what is fibrin?" in depth: how it forms, what happens when fibrin accumulates unchecked, and how fibrinolytic enzymes like nattokinase help restore healthy fibrin turnover.

What Is Fibrin? A Clear Definition

So what is fibrin, exactly? Fibrin is an insoluble protein that forms the structural framework of blood clots. When you cut yourself, your body launches a rapid cascade of chemical reactions called the coagulation cascade. The end result is fibrin — a mesh of tough protein strands that traps platelets and red blood cells to form a stable clot and stop the bleeding.

Fibrin is a fibrous protein that forms the structural scaffold of blood clots. When tissue is damaged, thrombin converts soluble fibrinogen into insoluble fibrin strands that cross-link into a mesh, trapping platelets and red blood cells to seal the wound.

Without fibrin, even minor injuries could lead to uncontrolled bleeding. Understanding what fibrin is at the molecular level reveals why this protein is one of the most essential components of your body's defense system.

What Is Fibrin Made Of? How It Forms in the Coagulation Cascade

Fibrin doesn't circulate in your blood in its active form. Instead, your liver produces a precursor protein called fibrinogen — one of the most abundant proteins in blood plasma. Here's how fibrinogen becomes fibrin:

Tissue damage triggers the cascade. When a blood vessel is injured, proteins called tissue factor (extrinsic pathway) or contact activation factors (intrinsic pathway) initiate a chain reaction of enzyme activations.
Both pathways converge on thrombin. The cascade funnels into a common pathway where prothrombin is converted to thrombin, the key enzyme in clot formation.
Thrombin cleaves fibrinogen into fibrin. Thrombin cuts two small peptide fragments from each fibrinogen molecule, exposing binding sites that allow fibrin monomers to self-assemble into long strands.
Factor XIIIa cross-links the fibrin mesh. Another enzyme, Factor XIIIa (activated by thrombin), creates covalent bonds between fibrin strands, transforming a fragile web into a robust, structural scaffold that anchors the blood clot.

This entire process takes seconds to minutes, depending on the severity of the injury. In healthy individuals, it's a precisely regulated system — fibrin forms where it's needed, does its job, and then gets cleared away.

What Is Fibrin Imbalance? Health Risks of Excess Fibrin

Now that you understand what fibrin is and how it forms, it's important to recognize when this protein becomes a problem. Fibrin becomes harmful when the balance between clot formation and clot breakdown tips in the wrong direction. Too much fibrin — or fibrin that resists normal breakdown — is linked to a wide range of serious health conditions.

Cardiovascular Disease and Stroke

Elevated fibrinogen levels are one of the strongest independent risk factors for cardiovascular disease. The landmark Framingham Study (Kannel et al., 1987) — which followed 1,315 participants over 12 years — found that each standard deviation increase associated with a 30% higher risk of coronary heart disease in men and 40% in women.

The Framingham Study established elevated fibrinogen as an independent cardiovascular risk factor — each standard deviation increase is associated with a 30–40% higher risk of coronary heart disease (Kannel et al., 1987). Meta-analysis data show per 1 g/L increase in plasma fibrinogen, coronary artery disease risk rises 142% and stroke risk rises 106% (Surma & Banach, 2022).

The mechanism is straightforward: excess fibrinogen means more raw material for fibrin formation. More fibrin means denser clots that form more easily and resist breakdown. A 2023 review in Cardiovascular Research (Ząbczyk et al., 2023) confirmed that cardiovascular disease is associated with "dense fibrin networks that are relatively resistant to enzymatic breakdown" — and that this prothrombotic fibrin phenotype independently predicts cardiovascular events.

Deep Vein Thrombosis and Pulmonary Embolism

Venous thromboembolism (VTE) — which includes deep vein thrombosis (DVT) and pulmonary embolism (PE) — affects an estimated 300,000 to 600,000 Americans annually. DVT occurs when a fibrin-rich blood clot forms in a deep vein, typically in the legs. If that clot breaks free and travels to the lungs, it becomes a pulmonary embolism, which can be fatal.

The core problem in VTE is excess fibrin deposition in the venous system, combined with insufficient fibrinolytic activity to clear it. Risk factors like prolonged immobility, surgery, and certain genetic conditions all shift the balance toward excess fibrin formation.

What Is Fibrin's Role in Atherosclerosis?

Fibrin doesn't just form acute blood clots. It also accumulates chronically within atherosclerotic plaques — the fatty deposits that narrow arteries over time. Fibrin and fibrinogen deposit in artery walls, promoting plaque growth, attracting inflammatory cells, and contributing to the instability that causes plaques to rupture and trigger heart attacks and strokes.

A review of the clinical literature (Surma & Banach, 2022) reported that meta-analysis data show per 1 g/L increase in plasma fibrinogen, coronary artery disease risk increases 142%, stroke risk increases 106%, and vascular death risk increases 176%.

Chronic Inflammation

Fibrin's role extends beyond clotting. Research now shows that fibrin and fibrinogen actively drive inflammatory processes throughout the body.

Fibrinogen and fibrin are not merely structural clotting proteins — a systematic review in Frontiers in Immunology found they function as active drivers of inflammation in the bloodstream and within tissues, contributing to conditions ranging from sepsis to multiple sclerosis (Göbel et al., 2018).

When fibrin deposits in tissues, it activates immune cells and triggers inflammatory signaling cascades. This creates a damaging feedback loop: inflammation promotes more fibrin deposition, and fibrin deposition promotes more inflammation. This cycle is implicated in conditions ranging from rheumatoid arthritis to neuroinflammatory diseases like multiple sclerosis.

What Is Fibrin's Connection to Long COVID? The Microclot Hypothesis

One of the most striking recent discoveries in fibrin research involves fibrin amyloid microclots — abnormal fibrin deposits that resist the body's normal breakdown processes.

Research has identified anomalous amyloid fibrin microclots — fibrin deposits that resist normal fibrinolysis — in long COVID patients. These microclots block capillaries and restrict oxygen transport, contributing to fatigue, brain fog, and breathlessness (Kell et al., 2022).

Research published in the Biochemical Journal (Kell et al., 2022) found that the SARS-CoV-2 spike protein can trigger fibrinogen to fold into an anomalous "amyloid" form that is resistant to normal fibrinolysis. These persistent microclots — measuring 1 to 200 micrometers in diameter — have been identified in the blood of long COVID patients using fluorescence microscopy.

The microclot hypothesis suggests that these fibrinolysis-resistant fibrin deposits block capillaries throughout the body, restricting oxygen delivery to tissues. This mechanism could explain many hallmark long COVID symptoms, including persistent fatigue, exercise intolerance, cognitive dysfunction ("brain fog"), and breathlessness. While the research is still evolving and requires larger controlled studies, it underscores the critical importance of healthy fibrin turnover.

Fibrinolysis: Your Body's Clot Cleanup System

If the coagulation cascade is the "on" switch for fibrin, fibrinolysis is the "off" switch. It's the body's built-in system for dissolving clots once they've done their job.

Fibrinolysis is the body's built-in system for dissolving blood clots after they've served their purpose. The inactive protein plasminogen is converted to plasmin — the body's primary clot-dissolving enzyme — by tissue plasminogen activator (tPA), then plasmin breaks down the fibrin mesh to restore normal blood flow.

Here's how the fibrinolytic system works:

Plasminogen circulates in your blood. This inactive protein is always present, waiting to be activated.
Tissue plasminogen activator (tPA) flips the switch. Released by endothelial cells lining blood vessels, tPA converts plasminogen into plasmin — the body's primary fibrin-dissolving enzyme.
Plasmin breaks down the fibrin mesh. Plasmin cleaves fibrin strands into smaller fragments called fibrin degradation products (FDPs), which are then cleared from the bloodstream.
PAI-1 applies the brakes. Plasminogen activator inhibitor-1 (PAI-1) prevents excessive fibrinolysis by deactivating tPA, ensuring that clots aren't dissolved prematurely.

When this system is in balance, blood clots form when needed and dissolve when they're no longer necessary. Problems arise when fibrinolysis can't keep up with fibrin production — a state called hypofibrinolysis — which leaves excess fibrin circulating in the blood and deposited in tissues.

What Is Fibrin Buildup Caused By? Factors That Impair Fibrinolysis

Several factors can shift the balance toward excess fibrin:

Aging: Fibrinolytic activity naturally declines with age while fibrinogen levels tend to rise
Elevated PAI-1: Higher levels of this inhibitor suppress plasmin production (common in obesity, metabolic syndrome, and diabetes)
Chronic inflammation: Inflammatory cytokines increase fibrinogen production and impair fibrinolysis simultaneously
Sedentary lifestyle: Physical inactivity is associated with reduced tPA release and impaired fibrinolytic capacity
Smoking: Increases fibrinogen levels and promotes a prothrombotic state
Viral infections: Certain viruses, including SARS-CoV-2, can trigger excessive fibrin deposition that overwhelms the fibrinolytic system

Fibrinolytic Enzymes: How Nattokinase Supports Fibrin Breakdown

Fibrinolytic enzymes are a class of proteins that break down fibrin. Your body produces its own (primarily plasmin), but supplemental fibrinolytic enzymes found in certain foods and supplements can provide additional support.

The most well-studied supplemental fibrinolytic enzyme is nattokinase, a serine protease originally discovered in natto — a traditional Japanese fermented soybean food — by Dr. Hiroyuki Sumi in 1987 (Sumi et al., 1987). When Dr. Sumi placed natto on an artificial blood clot, the enzyme dissolved it within 18 hours, launching decades of clinical research.

What Is Fibrin's Response to Nattokinase? Five Mechanisms

What makes nattokinase unique among fibrinolytic supplements is that it works through multiple mechanisms simultaneously:

Nattokinase works by directly cleaving fibrin and by activating the body's own plasminogen into plasmin, providing dual-pathway fibrinolytic activity.

1. Direct fibrinolysis: Nattokinase directly cleaves fibrin strands, physically breaking down the protein mesh that forms clots. In laboratory studies, it has demonstrated potency approximately four times greater than plasmin for thrombus dissolution (Chen et al., 2018).

2. Plasminogen activation: Nattokinase boosts the body's own fibrinolytic system by increasing conversion of plasminogen to plasmin.

3. tPA enhancement: Research shows nattokinase increases the release of tissue plasminogen activator (tPA), further amplifying the body's natural clot-dissolving capacity.

4. PAI-1 inactivation: Nattokinase cleaves and inactivates plasminogen activator inhibitor-1, removing a key brake on the fibrinolytic system.

5. Clotting factor reduction: A clinical study of 45 subjects by Hsia et al., 2009 found that nattokinase supplementation decreased fibrinogen levels by 7–9%, Factor VII by 13–14%, and Factor VIII by 17–19% over 8 weeks — meaning it reduces the raw materials for fibrin formation as well.

Unlike pharmaceutical thrombolytics that carry significant bleeding risk, nattokinase demonstrates fibrin specificity, meaning it preferentially breaks down fibrin clots without significantly affecting normal clotting factors.

The Clinical Evidence

The fibrinolytic effects of nattokinase have been demonstrated in multiple human studies:

Finding	Evidence	Source
Fibrinogen, Factor VII, Factor VIII reduction	9%, 14%, 17% decreases in healthy subjects	Hsia et al., 2009
Oral absorption confirmed	Fibrin degradation products elevated within 4 hours of single dose	Kurosawa et al., 2015
Blood pressure reduction	−5.55 mmHg systolic in RCT	Kim et al., 2008
Atherosclerotic plaque reduction	36.6% reduction in carotid plaque size over 26 weeks	Ren et al., 2017
Atherosclerosis management at scale	Significant reduction in 1,062 participants at 10,800 FU/day over 12 months	Chen et al., 2022
Strong safety profile	No serious adverse events at clinical doses	Multiple studies

Key finding: Research published in Scientific Reports confirmed that orally administered nattokinase is absorbed intact through the intestinal tract and retains its fibrinolytic activity in the bloodstream (Kurosawa et al., 2015).

Why Dosing Matters for Fibrinolytic Activity

The clinically studied dosage of nattokinase is 10,800 fibrinolytic units (FU), significantly higher than the 2,000 FU found in most commercial supplements.

Enzymatic reactions are dose-dependent. Below a certain threshold, there simply isn't enough enzyme activity to produce measurable fibrinolytic effects. The largest nattokinase clinical study to date (Chen et al., 2022), involving 1,062 participants, found that 10,800 FU per day was effective for managing atherosclerosis and hyperlipidemia, while a lower dose of 3,600 FU per day was ineffective.

A clinical study of 1,062 participants found that nattokinase at 10,800 FU per day co-administered with Vitamin K2 (180 μg/day) significantly reduced atherosclerosis and improved lipid profiles, while a lower dose of 3,600 FU per day was ineffective, demonstrating a clear dose-response relationship (Chen et al., 2022).

Key Takeaways: What Is Fibrin's Bottom Line?

Now that you have a full answer to the question "what is fibrin," here are the key points to remember. Understanding fibrin — what it does, why balance matters, and how your body clears it — is foundational to cardiovascular health:

Fibrin is essential. It's the structural protein that stops bleeding and repairs wounds. You cannot live without it.
Excess fibrin is dangerous. Elevated fibrinogen and impaired fibrinolysis are independent risk factors for heart disease, stroke, DVT, and chronic inflammation.
Fibrinolysis is your body's cleanup system. The plasminogen → plasmin pathway dissolves fibrin clots after they've served their purpose. When this system fails, fibrin accumulates.
Fibrinolytic enzymes can support the balance. Nattokinase, the most studied supplemental fibrinolytic enzyme, works through multiple mechanisms to both break down existing fibrin and reduce new fibrin formation.
Dose determines efficacy. Clinical evidence supports 10,800 FU per day as the effective dose for fibrinolytic activity — not the 2,000 FU found in most supplements.

Once you understand what fibrin is and how it affects cardiovascular health, the next logical question is how to support healthy fibrin balance. For a comprehensive overview of nattokinase — including benefits, dosage, side effects, and how to use it — see our guide: What Is Nattokinase?.

Supporting Healthy Fibrin Balance

Key finding: Toku Flow replicates the exact Chen et al. 2022 protocol — 10,800 FU nattokinase co-administered with 180 mcg Vitamin K2 (MK-7) daily — the combination shown effective in 1,062 participants over 12 months (Chen et al., 2022).

FAQs

What is fibrin in simple terms?

What is fibrin? In simple terms, fibrin is a protein your body makes to form blood clots. When you're injured, fibrin creates a mesh-like scaffold that traps blood cells and seals the wound. Think of it as the body's natural bandage material.

What is fibrin made of?

Fibrin is made from fibrinogen, a soluble plasma protein produced by the liver. When tissue is damaged, the enzyme thrombin cleaves fibrinogen into fibrin monomers, which then cross-link into a tough, insoluble mesh. Asking "what is fibrin made of" is really asking about fibrinogen — the precursor molecule.

What happens when fibrin levels are too high?

Excess fibrin or elevated fibrinogen increases the risk of dangerous blood clots, cardiovascular disease, stroke, and chronic inflammation. The Framingham Study showed elevated fibrinogen is an independent risk factor comparable to high blood pressure or smoking.

What is fibrinolysis and how does it relate to fibrin?

Fibrinolysis is the body's natural process for dissolving blood clots. The key enzyme is plasmin, which is activated from plasminogen by tissue plasminogen activator (tPA). Plasmin breaks down fibrin into smaller fragments that are cleared from the bloodstream, restoring normal blood flow.

How does nattokinase break down fibrin?

Nattokinase works through multiple mechanisms: it directly cleaves fibrin strands, activates the body's plasminogen into plasmin, increases tPA release, inactivates PAI-1 (a fibrinolysis inhibitor), and reduces fibrinogen and clotting factor levels. This multi-pathway approach both supplements and amplifies the body's own fibrinolytic system.

What is fibrin's role in long COVID?

Research has identified fibrin amyloid microclots — abnormal fibrin deposits that resist the body's normal breakdown processes — in long COVID patients. These microclots may block capillaries and restrict oxygen delivery, potentially contributing to fatigue, brain fog, and other symptoms.

Can fibrinolytic enzymes like nattokinase replace blood thinners?

No. Nattokinase is a dietary supplement, not a pharmaceutical, and should never replace prescribed anticoagulant medications. If you are taking blood thinners, consult your doctor before taking nattokinase, as the combination could increase bleeding risk.

Toku Flow 10,800 FU Nattokinase Supplement | Soy Free Powder

$179.97

High-Potency Nattokinase Supplement for Cardiovascular Health & CirculationToku Flow delivers 10,800 FU of clinical-grade nattokinase per daily sachet, paired with Vitamin K2 (MK-7) and oat beta-glucan for comprehensive cardiovascular support. Sourced from chickpea fermentation (soy-free), third-party tested, no fillers.… read more

What Is Fibrin? The Protein Behind Blood Clots

Table of Contents

What Is Fibrin? The Protein Behind Blood Clots

Quick Answer

What Is Fibrin? A Clear Definition

What Is Fibrin Made Of? How It Forms in the Coagulation Cascade